Mohamed Magdy Ibrahim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mohamed Magdy Ibrahim has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Howard Levinson
Division of Plastic, Maxillofacial, and Oral Surgery, Department of Surgery, Duke University Health System, Durham, NC, USA
6 shared publications Bruce Klitzman
Duke University School of Medicine
3 shared publicationsManuel A. Medina
Division of Plastic and Reconstructive Surgery, Department of Surgery, Duke University School of Medicine, Durham, USA
3 shared publicationsCarlos Quiles
Division of Plastic and Reconstructive Surgery, Department of Surgery, Duke University School of Medicine, Durham, USA
2 shared publicationsElizabeth R. Lorden
Department of Biomedical Engineering, Duke University, Box 90281, Durham, NC 27708, USA
2 shared publicationsGeorge Kokosis
Division of Plastic and Reconstructive Surgery, Department of Surgery, Duke University School of Medicine, Durham, USA
2 shared publications
Latest Publications
- 4 September 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11  (10) , 8925-8936
Development and Assessment of Poly(ethylene glycol) Diacrylate-Embedded Metalloporphyrin for Phosphorescence Lifetime-Based In Vivo Monitoring of Oxygen Tension
The timely detection of ischemia is crucial for enhancing outcomes in reconstructive surgery. This study presents the development and in vivo evaluation of a metalloporphyrin-based phosphorescence lifetime oxygen sensor embedded in poly(ethylene glycol) diacrylate (PEGDA) hydrogel for monitoring local tissue oxygen tension (TOT). Palladium(II) tetraphenyltetrabenzoporphyrin was incorporated into microporous PEGDA hydrogels using polystyrene to facilitate dispersion and enhance photophysical properties. Sensors were calibrated under controlled oxygen conditions and characterized for oxygen-dependent phosphorescence lifetime response. In vivo performance was assessed using rat flap models and a swine tongue ischemia model. Implant localization and local tissue response were evaluated using luminescence imaging and histological analysis. The sensors demonstrated an inverse relationship between phosphorescence lifetime and pO2, with a dynamic response to experimentally varied oxygen conditions. In vivo, the sensors detected regional oxygen differences associated with ischemia and areas that later developed tissue necrosis in flap models. In the rat pedicle flap model, a decrease in oxygenation was detected within approximately 70 s of vascular clamping. In the swine tongue model, sensors detected acute oxygenation changes during vascular compromise and partial recovery after tourniquet release and tongue massage. Implants remained localized without visible migration, and histological analysis showed no granulomatous inflammation or multinucleated giant-cell reaction over the 28-day study period. This injectable PEGDA-embedded metalloporphyrin sensor enables non-invasive phosphorescence lifetime-based monitoring of local tissue oxygen tension after implantation. Its oxygen-responsive lifetime behavior, short-term positional stability, and proof-of-concept ischemia detection support further development as a localized monitoring tool for surgical tissue viability.
- 4 September 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11  (10) , 8925-8936
Development and Assessment of Poly(ethylene glycol) Diacrylate-Embedded Metalloporphyrin for Phosphorescence Lifetime-Based In Vivo Monitoring of Oxygen Tension
The timely detection of ischemia is crucial for enhancing outcomes in reconstructive surgery. This study presents the development and in vivo evaluation of a metalloporphyrin-based phosphorescence lifetime oxygen sensor embedded in poly(ethylene glycol) diacrylate (PEGDA) hydrogel for monitoring local tissue oxygen tension (TOT). Palladium(II) tetraphenyltetrabenzoporphyrin was incorporated into microporous PEGDA hydrogels using polystyrene to facilitate dispersion and enhance photophysical properties. Sensors were calibrated under controlled oxygen conditions and characterized for oxygen-dependent phosphorescence lifetime response. In vivo performance was assessed using rat flap models and a swine tongue ischemia model. Implant localization and local tissue response were evaluated using luminescence imaging and histological analysis. The sensors demonstrated an inverse relationship between phosphorescence lifetime and pO2, with a dynamic response to experimentally varied oxygen conditions. In vivo, the sensors detected regional oxygen differences associated with ischemia and areas that later developed tissue necrosis in flap models. In the rat pedicle flap model, a decrease in oxygenation was detected within approximately 70 s of vascular clamping. In the swine tongue model, sensors detected acute oxygenation changes during vascular compromise and partial recovery after tourniquet release and tongue massage. Implants remained localized without visible migration, and histological analysis showed no granulomatous inflammation or multinucleated giant-cell reaction over the 28-day study period. This injectable PEGDA-embedded metalloporphyrin sensor enables non-invasive phosphorescence lifetime-based monitoring of local tissue oxygen tension after implantation. Its oxygen-responsive lifetime behavior, short-term positional stability, and proof-of-concept ischemia detection support further development as a localized monitoring tool for surgical tissue viability.
- Open Access
- 15 July 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39  (7) , e70237
Evaluating Hyperparathyroidism in Simultaneous PancreasâKidney Transplant Recipients: A SingleâCenter Experience
Introduction: Cardiovascular disease remains the primary cause of mortality after kidney transplantation. Hyperparathyroidism (HPT) may contribute to the accelerated progression of coronary artery disease (CAD) and peripheral artery disease (PAD), particularly in transplant patients. This is particularly true when HPT overlaps with both renal failure and diabetes. Scant data exist to support medical or surgical management of tertiary hyperparathyroidism (3HPT) in simultaneous pancreasâkidney (SPK) transplant recipients. This study evaluates the outcomes of cardiovascular disease, bone health, and kidney and pancreas graft function as they relate to HPT in SPK recipients.Methods: Patients who received SPK transplantation at a large academic center were reviewed. Patient demographics, transplant specifics, evidence of HPT, graft survival, and mortality were collected. Patients were categorized as either resolved HPT or unresolved HPT (developed 3HPT). Independent group tâtests and Fisher's exact tests were used for bivariate comparisons.Results: Over 7 years, 132 patients received SPK transplantation. 41.7% of patients resolved HPT, and 58.3% of patients developed 3HPT. Those with 3HPT had significantly lower eGFR at 3 years (51.16 Âą 21.58 vs. 62.55 Âą 19.56 mL/min/1.73m2, p = 0.009) and higher HbA1c (6.05 Âą 1.56 vs. 5.61 Âą 0.83, p = 0.047). All patients experienced worsening radiographic evidence of large vessel calcifications (p < 0.001).Conclusions: 3HPT after SPK transplant is associated with worse function of both the renal and pancreatic grafts and peripheral arterial disease compared to those without 3HPT. A larger prospective cohort study is needed to determine causal relationships and develop treatment guidelines.
- 15 July 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39  (7) , e70237
Open AccessEvaluating Hyperparathyroidism in Simultaneous PancreasâKidney Transplant Recipients: A SingleâCenter Experience
Introduction: Cardiovascular disease remains the primary cause of mortality after kidney transplantation. Hyperparathyroidism (HPT) may contribute to the accelerated progression of coronary artery disease (CAD) and peripheral artery disease (PAD), particularly in transplant patients. This is particularly true when HPT overlaps with both renal failure and diabetes. Scant data exist to support medical or surgical management of tertiary hyperparathyroidism (3HPT) in simultaneous pancreasâkidney (SPK) transplant recipients. This study evaluates the outcomes of cardiovascular disease, bone health, and kidney and pancreas graft function as they relate to HPT in SPK recipients.Methods: Patients who received SPK transplantation at a large academic center were reviewed. Patient demographics, transplant specifics, evidence of HPT, graft survival, and mortality were collected. Patients were categorized as either resolved HPT or unresolved HPT (developed 3HPT). Independent group tâtests and Fisher's exact tests were used for bivariate comparisons.Results: Over 7 years, 132 patients received SPK transplantation. 41.7% of patients resolved HPT, and 58.3% of patients developed 3HPT. Those with 3HPT had significantly lower eGFR at 3 years (51.16 Âą 21.58 vs. 62.55 Âą 19.56 mL/min/1.73m2, p = 0.009) and higher HbA1c (6.05 Âą 1.56 vs. 5.61 Âą 0.83, p = 0.047). All patients experienced worsening radiographic evidence of large vessel calcifications (p < 0.001).Conclusions: 3HPT after SPK transplant is associated with worse function of both the renal and pancreatic grafts and peripheral arterial disease compared to those without 3HPT. A larger prospective cohort study is needed to determine causal relationships and develop treatment guidelines.
- 8 January 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39  (1) , e70079
Use of LCPâTacrolimus in Kidney Transplant Recipients With Altered Gastrointestinal Anatomy
- 8 January 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39  (1) , e70079
Use of LCPâTacrolimus in Kidney Transplant Recipients With Altered Gastrointestinal Anatomy
- 23 August 2023
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 8  (6) , 1178-1183
A Curious Case of Anti-Human Leukocyte Antigen-Bw4 Antibody in a Kidney Transplant Candidate
A 49-year-old White female with end-stage renal disease was referred to our medical center for evaluation as a kidney transplant candidate. Her past medical history was remarkable for an episode of bacterial meningitis complicated by septic shock and acute kidney injury at the age of 24. Her renal function never recovered and continued to decline, with an estimated glomerular filtration rate below 15 mL/min/1.73 m2 at presentation. Further workup after the septic shock led to the diagnosis of common variable immunodeficiency (CVID), and she has been receiving chronic subcutaneous immunoglobulin (SCIG) injections once weekly (12 gm per dose; HizentraÂŽ) with good prevention of infections. She was pregnant once, ending in an abortion followed by a hysterectomy. She also had a history of amoxicillin/clavulanate-induced immune thrombocytopenic purpura, cephalexin-induced hemolytic anemia, and pulmonary nodules with scarring on the chest x-ray. After 9 months of waiting for a deceased-donor kidney, a healthy unrelated living donor became available for the patient. Human leukocyte antigen (HLA) typing and anti-HLA antibody screens were performed to assess their compatibility ( Fig. 1A). Compared with the patientâs HLA typing, the donor had 6 mismatched antigens: A24, A29, B13, B58, DR8, and DQ4. Three of the mismatched class I antigens, A24, B13, and B58, shared the Bw4-related epitope as defined by a cluster of isoleucine (I) or threonine (T) at position 80, leucine (L) at position 82, and arginine (R) at position 83 (80I/T + 82L83R; Fig. 1B). The patient was negative for Bw4 and carried the antithetical, Bw6-related epitope with a characteristic asparagine (N) at position 80 ( Fig. 1A).
- 23 August 2023
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 8  (6) , 1178-1183
A Curious Case of Anti-Human Leukocyte Antigen-Bw4 Antibody in a Kidney Transplant Candidate
A 49-year-old White female with end-stage renal disease was referred to our medical center for evaluation as a kidney transplant candidate. Her past medical history was remarkable for an episode of bacterial meningitis complicated by septic shock and acute kidney injury at the age of 24. Her renal function never recovered and continued to decline, with an estimated glomerular filtration rate below 15 mL/min/1.73 m2 at presentation. Further workup after the septic shock led to the diagnosis of common variable immunodeficiency (CVID), and she has been receiving chronic subcutaneous immunoglobulin (SCIG) injections once weekly (12 gm per dose; HizentraÂŽ) with good prevention of infections. She was pregnant once, ending in an abortion followed by a hysterectomy. She also had a history of amoxicillin/clavulanate-induced immune thrombocytopenic purpura, cephalexin-induced hemolytic anemia, and pulmonary nodules with scarring on the chest x-ray. After 9 months of waiting for a deceased-donor kidney, a healthy unrelated living donor became available for the patient. Human leukocyte antigen (HLA) typing and anti-HLA antibody screens were performed to assess their compatibility ( Fig. 1A). Compared with the patientâs HLA typing, the donor had 6 mismatched antigens: A24, A29, B13, B58, DR8, and DQ4. Three of the mismatched class I antigens, A24, B13, and B58, shared the Bw4-related epitope as defined by a cluster of isoleucine (I) or threonine (T) at position 80, leucine (L) at position 82, and arginine (R) at position 83 (80I/T + 82L83R; Fig. 1B). The patient was negative for Bw4 and carried the antithetical, Bw6-related epitope with a characteristic asparagine (N) at position 80 ( Fig. 1A).
- Open Access
- 28 March 2022
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 53  (4) , 331-332
Kidney Transplantation from COVID-19 Deceased Donors: New Hope on the Horizon
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
- 28 March 2022
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 53  (4) , 331-332
Open AccessKidney Transplantation from COVID-19 Deceased Donors: New Hope on the Horizon
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
- 20 September 2019
- Published by ASME International in Journal of Medical Devices
- Vol. 13  (4) , 0450021-0450029
Soft Tissue Anchoring Performance, Biomechanical Properties, and Tissue Reaction of a New Hernia Mesh Engineered to Address Hernia Occurrence and Recurrence
One opportunity to reduce hernia occurrence and recurrence rates (currently estimated to be 30% at 10 years postoperatively) is by enhancing the ability of hernia meshes to anchor into tissue to prevent mesh migration, mesh contraction, and mesh tearing away from tissue. To address this, we developed a novel moderate-weight, macroporous, polypropylene mesh (termed the T-line mesh) with mesh extensions to optimize anchoring. We examined the physical properties, biomechanical performance, and biocompatibility of this novel mesh versus a predicate mesh anchored with #0-suture. The physical properties of the T-line mesh and predicate mesh were measured using American Society for Testing and Materials (ASTM) standards. Meshes were implanted into a swine hernia model and harvested after one day to determine anchoring strength of the meshes in the perioperative period. A separate group was implanted into a swine hernia model and harvested at 30 days and 90 days for semiquantitative histological analysis of biocompatibility. T-line mesh physical properties were similar to commonly used moderate-weight meshes in thickness and areal density. The T-line mesh outperformed the predicate mesh in all mechanical testing (P < 0.05). In the perioperative period, the T-line mesh was âź275% stronger (P < 0.001) than the standard of care. Histological analysis of biocompatibility demonstrated no significant difference between the T-line mesh and predicate mesh (P > 0.05). The T-line mesh is a novel hernia mesh that outperforms a predicate mesh in mechanical and biomechanical performance testing while exhibiting similar biocompatibility. The T-line mesh has the potential to reduce hernia occurrence and recurrence caused by mechanical failure.
- 20 September 2019
- Published by ASME International in Journal of Medical Devices
- Vol. 13  (4) , 0450021-0450029
Soft Tissue Anchoring Performance, Biomechanical Properties, and Tissue Reaction of a New Hernia Mesh Engineered to Address Hernia Occurrence and Recurrence
One opportunity to reduce hernia occurrence and recurrence rates (currently estimated to be 30% at 10 years postoperatively) is by enhancing the ability of hernia meshes to anchor into tissue to prevent mesh migration, mesh contraction, and mesh tearing away from tissue. To address this, we developed a novel moderate-weight, macroporous, polypropylene mesh (termed the T-line mesh) with mesh extensions to optimize anchoring. We examined the physical properties, biomechanical performance, and biocompatibility of this novel mesh versus a predicate mesh anchored with #0-suture. The physical properties of the T-line mesh and predicate mesh were measured using American Society for Testing and Materials (ASTM) standards. Meshes were implanted into a swine hernia model and harvested after one day to determine anchoring strength of the meshes in the perioperative period. A separate group was implanted into a swine hernia model and harvested at 30 days and 90 days for semiquantitative histological analysis of biocompatibility. T-line mesh physical properties were similar to commonly used moderate-weight meshes in thickness and areal density. The T-line mesh outperformed the predicate mesh in all mechanical testing (P < 0.05). In the perioperative period, the T-line mesh was âź275% stronger (P < 0.001) than the standard of care. Histological analysis of biocompatibility demonstrated no significant difference between the T-line mesh and predicate mesh (P > 0.05). The T-line mesh is a novel hernia mesh that outperforms a predicate mesh in mechanical and biomechanical performance testing while exhibiting similar biocompatibility. The T-line mesh has the potential to reduce hernia occurrence and recurrence caused by mechanical failure.
- 1 February 2019
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 82  (2) , 229-232
International Medical Graduates and the Integrated Plastic Surgery Residency Match
Plastic surgery continues to be one of the most competitive programs into which medical students attempt to match. The reasons for this include the complexity and diversity of cases, the opportunity to interact with multiple specialties, patient and surgeon satisfaction, and the potential for higher compensation compared with other specialties. The disparity between the relatively small number of plastic surgery residency positions and the large number of highly competitive candidates has created challenges for both the applicant and the residency program director. This challenge is even greater for international medical graduates because of traditional preconceived notions about the quality of the applicants. The authors sought to determine existing beliefs about international medical graduates among plastic surgeons.
- 1 February 2019
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 82  (2) , 229-232
International Medical Graduates and the Integrated Plastic Surgery Residency Match
Plastic surgery continues to be one of the most competitive programs into which medical students attempt to match. The reasons for this include the complexity and diversity of cases, the opportunity to interact with multiple specialties, patient and surgeon satisfaction, and the potential for higher compensation compared with other specialties. The disparity between the relatively small number of plastic surgery residency positions and the large number of highly competitive candidates has created challenges for both the applicant and the residency program director. This challenge is even greater for international medical graduates because of traditional preconceived notions about the quality of the applicants. The authors sought to determine existing beliefs about international medical graduates among plastic surgeons.
- 13 July 2018
- Published by ASME International in Journal of Medical Devices
- Vol. 12  (3) , 035001
Creating a Small Anchor to Eliminate Large Knots in Mesh and Tape Suture
Wide mesh or tape sutures are used to close high-tension wounds such as in hernia or tendon repair. However, wide sutures produce large knots that are susceptible to increased palpability, infection, and foreign body response. To prevent such adverse events, we developed a small suture anchor to replace wide suture knots. The suture anchor was iteratively developed using three-dimensional (3D) design software and produced via 3D printing. Anchor prototypes underwent monotonic, cyclic fatigue, and stress-life testing in a benchtop soft tissue suture model. Results were compared to a standard of care knot and alternative suture fixation devices. The final anchor design was selected based on minimal size and mechanical performance. The size of the final anchor (200 mm3) was 33% smaller than a tape suture knot and 68% smaller than a mesh suture knot. Monotonic testing of mesh and tape sutures revealed a significantly greater anchor failure load compared to knot and alternative fixations (p < 0.05). Additionally, all anchors successfully completed cyclic fatigue testing without failure while other fixations, including knot, failed to complete cyclic fatigue testing multiple times. Stress-life testing demonstrated durable anchor fixation under varying tensile stresses. Failure mode analysis revealed anchor fracture and tissue failure as modes of anchor failure, each of which occurred at supraphysiologic forces. We created a small suture anchor that significantly outperforms knot and alternative suture fixations in benchtop testing and addresses concerns of increased palpability, infection, and foreign body response from large suture knots.
- 13 July 2018
- Published by ASME International in Journal of Medical Devices
- Vol. 12  (3) , 035001
Creating a Small Anchor to Eliminate Large Knots in Mesh and Tape Suture
Wide mesh or tape sutures are used to close high-tension wounds such as in hernia or tendon repair. However, wide sutures produce large knots that are susceptible to increased palpability, infection, and foreign body response. To prevent such adverse events, we developed a small suture anchor to replace wide suture knots. The suture anchor was iteratively developed using three-dimensional (3D) design software and produced via 3D printing. Anchor prototypes underwent monotonic, cyclic fatigue, and stress-life testing in a benchtop soft tissue suture model. Results were compared to a standard of care knot and alternative suture fixation devices. The final anchor design was selected based on minimal size and mechanical performance. The size of the final anchor (200 mm3) was 33% smaller than a tape suture knot and 68% smaller than a mesh suture knot. Monotonic testing of mesh and tape sutures revealed a significantly greater anchor failure load compared to knot and alternative fixations (p < 0.05). Additionally, all anchors successfully completed cyclic fatigue testing without failure while other fixations, including knot, failed to complete cyclic fatigue testing multiple times. Stress-life testing demonstrated durable anchor fixation under varying tensile stresses. Failure mode analysis revealed anchor fracture and tissue failure as modes of anchor failure, each of which occurred at supraphysiologic forces. We created a small suture anchor that significantly outperforms knot and alternative suture fixations in benchtop testing and addresses concerns of increased palpability, infection, and foreign body response from large suture knots.
- 1 April 2018
- Published by Elsevier in Journal of Biomechanics
- Vol. 71, 43-51
Modifying hernia mesh design to improve device mechanical performance and promote tension-free repair
- 1 April 2018
- Published by Elsevier in Journal of Biomechanics
- Vol. 71, 43-51
Modifying hernia mesh design to improve device mechanical performance and promote tension-free repair